Compare ASMB & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASMB | GPRK |
|---|---|---|
| Founded | 2005 | 2002 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 397.8M |
| IPO Year | 2010 | 2009 |
| Metric | ASMB | GPRK |
|---|---|---|
| Price | $28.30 | $8.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $43.40 | $8.50 |
| AVG Volume (30 Days) | 92.6K | ★ 685.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.38% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $33.33 | N/A |
| Revenue Next Year | N/A | $23.25 |
| P/E Ratio | ★ N/A | $12.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.76 | $5.66 |
| 52 Week High | $39.71 | $9.09 |
| Indicator | ASMB | GPRK |
|---|---|---|
| Relative Strength Index (RSI) | 48.18 | 62.05 |
| Support Level | $26.50 | $7.84 |
| Resistance Level | $30.66 | $9.09 |
| Average True Range (ATR) | 1.46 | 0.37 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 36.74 | 85.60 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.